Skip to main content
Caplight Logo









BDI Biotech

BDI Biotech

Private
ValladolidHealthcare & Life Scienceshttps://www.bdibiotech.com/

Last Round

Secondary

Mar 31, 2026

Est. Valuation

$54.55M

Total Funding Raised

$2.32M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

BDI Biotech is a biotechnology company that provides R&D and contract manufacturing services, specializing in strain development, bioprocess scale-up, and production for the cosmetic, nutraceutical, and live biotherapeutic industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CDMOcontract development and manufacturing organizationbioprocess scale-upstrain developmentcontract manufacturingbiotech outsourcingbiotransformationlive biotherapeutic productLBPfermentation servicesbiotech R&Dlab-to-pilot scaleprocess optimizationbio-based ingredientsbiotech services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BDI Biotech Comparables

Compare BDI Biotech with similar companies based on industry and business-model similarity.

BDI Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioCina
79%
53Biologics
78%
Wacker Chemie AG
77%

BDI Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SecondaryMar 31, 2026
GrantSep 19, 2022
VC RoundSep 10, 2021
SeedJan 4, 2018

BDI Biotech Investors

Notable investors and investment history

BDI Biotech investors
InvestorRounds
InvereadyVC Round, Seed
Ren Life SciencesSecondary
Spanish Ministry of Industry and TourismGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Monthly visitors grew 4848% MoM, from 123 to 6.1K.

  • Mar 31, 2026

    Raised $54.55M at post-money valuation led by Ren Life Sciences.

BDI Biotech Filings

Explore SEC and related filing metadata, where available.

BDI Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BDI Biotech's valuation, stock price, and market status.

Is BDI Biotech a public or private company?

BDI Biotech is a private company.

What is the current stock price of BDI Biotech?

BDI Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is BDI Biotech worth (valuation)?

BDI Biotech's valuation is estimated at $54.5M based on funding round data.

Can I buy BDI Biotech stock?

BDI Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BDI Biotech's last funding round?

BDI Biotech's most recent funding round was Secondary on March 31, 2026.

Who are the main investors in BDI Biotech?

Key investors in BDI Biotech include Inveready, Ren Life Sciences.

Will BDI Biotech IPO soon?

No public IPO plans have been announced for BDI Biotech.

How can I track BDI Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BDI Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersValladolid
Employee Range33
Year Founded2011
Last FundingMar 31, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?